Literature DB >> 15313368

Glucagon-like peptide-2: divergent signaling pathways.

Flavio G Rocha1, K Robert Shen, Jasleen Jasleen, Ali Tavakkolizadeh, Michael J Zinner, Edward E Whang, Stanley W Ashley.   

Abstract

BACKGROUND AND AIMS: Glucagon-like peptide 2 (GLP-2) is an endogenous hormone with potent and specific intestinotrophic activity in vivo and in vitro. The aim of this study was to define the initial signal transduction mechanisms mediating the proliferative actions of GLP-2 on intestinal epithelial cells.
METHODS: The proliferative actions of GLP-2 on the human Caco-2 cell line were assessed. Specific G-protein inhibitors, pertussis and cholera toxin, were used to characterize the roles of early signal transduction mechanisms in mediating the proliferative actions of GLP-2 in these cells.
RESULTS: GLP-2 directly stimulated proliferation in the Caco-2 cells. GLP-2 stimulated proliferation was (1) inhibited in a dose-dependent fashion by both pertussis and cholera toxin and (2) augmented by 2',5'-dideoxyadenosine. Proliferation rates were inversely proportional to changes in intracellular cAMP concentration.
CONCLUSIONS: Our findings suggest that a G-protein-linked signaling pathway is involved with GLP-2 bioactivity in the intestinal epithelial cell line Caco-2.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15313368     DOI: 10.1016/j.jss.2004.04.009

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  9 in total

Review 1.  Gut hormones, and short bowel syndrome: the enigmatic role of glucagon-like peptide-2 in the regulation of intestinal adaptation.

Authors:  G-R Martin; P-L Beck; D-L Sigalet
Journal:  World J Gastroenterol       Date:  2006-07-14       Impact factor: 5.742

2.  Glucagon-like peptide-2 induces a specific pattern of adaptation in remnant jejunum.

Authors:  D L Sigalet; O Bawazir; G R Martin; L E Wallace; G Zaharko; A Miller; A Zubaidi
Journal:  Dig Dis Sci       Date:  2006-08-22       Impact factor: 3.199

3.  Glucagon-like peptide-2 protects impaired intestinal mucosal barriers in obstructive jaundice rats.

Authors:  Jun Chen; Jia-Tian Dong; Xiao-Jing Li; Ye Gu; Zhi-Jian Cheng; Yuan-Kun Cai
Journal:  World J Gastroenterol       Date:  2015-01-14       Impact factor: 5.742

4.  Disruption of the murine Glp2r impairs Paneth cell function and increases susceptibility to small bowel enteritis.

Authors:  Seung-Jun Lee; Jennifer Lee; Karen K Li; Dianne Holland; Heather Maughan; David S Guttman; Bernardo Yusta; Daniel J Drucker
Journal:  Endocrinology       Date:  2012-01-17       Impact factor: 4.736

5.  Synergistic effect of glucagon-like peptide 2 (GLP-2) and of key growth factors on the proliferation of cultured rat astrocytes. Evidence for reciprocal upregulation of the mRNAs for GLP-2 and IGF-I receptors.

Authors:  Esther Velázquez; Enrique Blázquez; Juan Miguel Ruiz-Albusac
Journal:  Mol Neurobiol       Date:  2009-08-13       Impact factor: 5.590

Review 6.  Intestinal hormones and growth factors: effects on the small intestine.

Authors:  Laurie Drozdowski; Alan B R Thomson
Journal:  World J Gastroenterol       Date:  2009-01-28       Impact factor: 5.742

7.  Emerging treatment options for short bowel syndrome: potential role of teduglutide.

Authors:  Cheng T Tee; Katharina Wallis; Simon M Gabe
Journal:  Clin Exp Gastroenterol       Date:  2011-08-19

8.  Molecular mechanisms mediating the G protein-coupled receptor regulation of cell cycle progression.

Authors:  David C New; Yung H Wong
Journal:  J Mol Signal       Date:  2007-02-26

9.  GLP-2 Attenuates LPS-Induced Inflammation in BV-2 Cells by Inhibiting ERK1/2, JNK1/2 and NF-κB Signaling Pathways.

Authors:  Nan Li; Bo-Wen Liu; Wen-Zhi Ren; Ju-Xiong Liu; Su-Nan Li; Shou-Peng Fu; Ya-Long Zeng; Shi-Yao Xu; Xuan Yan; Ying-Jie Gao; Dian-Feng Liu; Wei Wang
Journal:  Int J Mol Sci       Date:  2016-02-04       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.